MIRA INFORM REPORT

 

 

Report Date :

25.08.2014 

 

IDENTIFICATION DETAILS

 

Name :

INTERNATIONAL PHARMACEUTICAL GENERICS LTD

 

 

Registered Office :

77 Auriga Drive, Ste 4, Ottawa, Ontario K2E 7Z7

 

 

Country :

Canada

 

 

Date of Incorporation :

18.11.2005

 

 

Legal Form :

Corporation – Profit

 

 

Line of Business :

Subject is a professionally managed organization in the business of licensing, importing and distributing Pharmaceutical.

 

 

No. of Employees

05

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Small Business

Payment Behaviour :

No complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Canada

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

CANADA ECONOMIC OVERVIEW

 

As a high-tech industrial society in the trillion-dollar class, Canada resembles the US in its market-oriented economic system, pattern of production, and high living standards. Since World War II, the impressive growth of the manufacturing, mining, and service sectors has transformed the nation from a largely rural economy into one primarily industrial and urban. The 1989 US-Canada Free Trade Agreement (FTA) and the 1994 North American Free Trade Agreement (NAFTA) (which includes Mexico) touched off a dramatic increase in trade and economic integration with the US, its principal trading partner. Canada enjoys a substantial trade surplus with the US, which absorbs about three-fourths of Canadian merchandise exports each year. Canada is the US's largest foreign supplier of energy, including oil, gas, uranium, and electric power. Given its abundant natural resources, highly skilled labor force, and modern capital plant, Canada enjoyed solid economic growth from 1993 through 2007. Buffeted by the global economic crisis, the economy dropped into a sharp recession in the final months of 2008, and Ottawa posted its first fiscal deficit in 2009 after 12 years of surplus. Canada's major banks, however, emerged from the financial crisis of 2008-09 among the strongest in the world, owing to the financial sector's tradition of conservative lending practices and strong capitalization. Canada achieved marginal growth in 2010-13 and plans to balance the budget by 2015. In addition, the country's petroleum sector is rapidly expanding, because Alberta's oil sands significantly boosted Canada's proven oil reserves. Canada now ranks third in the world in proved oil reserves behind Saudi Arabia and Venezuela

 

Source : CIA

 

 

 

company name and address

 

Company name:             INTERNATIONAL PHARMACEUTICAL GENERICS LTD

 

Address:                       77 Auriga Drive, Ste 4, Ottawa, Ontario K2E 7Z7 - Canada

 

Telephone:                     +1 603-228-2600

 

Fax:                              +1 603-224-0444

 

Website:                       www.ipgenerics.com

 

Corporate ID#:               ON-0001663300

 

State:                           Ontario

 

Judicial form:                 Corporation – Profit

 

Date incorporated:          11-18-2005

 

Stock:                            -

           

Value:                            -

 

Name of manager:           Atul AGGARWAL

 

 

ACTIVITIES & OPERATIONS

 

IST

 

Business:

 

International Pharmaceutical Generics (IPG) Limited is a professionally managed organization in the business of licensing, importing and distributing Pharmaceutical, Over the Counter and Nutritional finished formulations to Pharmaceutical, Over the Counter manufacturers and marketers in Canada.

 

 

No name of foreign suppliers available.

 

Staff:     5

 

 

Operations & branches:

 

At the headquarters, we find the corporate office.

 

 

SHAREHOLDERS & MANAGERS

 

Shareholders:

 

INTERNATIONAL PHARMACEUTICAL GENERICS HOLDINGS INC.

Incorporated in Ontario on March 5, 2012

ID# ON-000186066

 

 

Management:

 

Atul AGGARWAL is the President.

MBA from Wilfrid Laurier University in 1989

 

He is also the President of

 

A&A PHARMACHEM INC.

77 Auriga Drive, Ste 4, Ottawa, Ontario K2E 7Z7

Incorporated in Ontario on 10-24-1991

ID# ON-0000951172

 

MARCAN PHARMACEUTICALS INC.

77 Auriga Drive, Ste 4, Ottawa, Ontario K2E 7Z7

 

Sudheer PALADUGU is Vice President and CTO.

 

 

FINANCIALS

 

In Canada, privately held corporations are not required to publish any financials.

 

On a direct call, nobody accepted to answer our questions.

We sent a fax but no answer received.

 

However, sales estimate for year 2013 is in the range of CAD 1,000,000=

(same as 2012)

 

The business is profitable.

 

Banks:  Royal Bank of Canada               

 

 

LEGAL FILINGS

 

Legal filings & complaints:

 

As of today date, there is no legal filing pending with the Courts.

 

Secured debts summary:   None

 

 

COMPANY CREDIT HISTORY

 

Trade references:

 

Date reported:                July 2014

High credit:                    CAD 8,000+

Now owing:                    0

Past due:                      0

Last purchase:               June 2014

Line of business:            Payroll

Paying status:               As agreed

 

Date reported:                July 2014

High credit:                    CAD 600

Now owing:                    0

Past due:                      0

Last purchase:              June 2014

Line of business:            Telecommunications

Paying status:               On terms

 

 

Domestic credit history:

 

Domestic credit history appears as follow:

 

Monthly Payment Trends - Recent Activity

 

 

Date

Balance

Current

Up to 30 DBT

31-60 DBT

61-90 DBT

>90 DBT

11/12

$1,000

100%

0%

0%

0%

0%

12/12

$1,000

100%

0%

0%

0%

0%

01/13

$1,000

100%

0%

0%

0%

0%

02/13

$1,100

100%

0%

0%

0%

0%

03/13

$1,100

100%

0%

0%

0%

0%

04/13

$1,100

100%

0%

0%

0%

0%

 

 

National Credit Bureaus gave a satisfying credit rating.

 

 

International credit history:

 

Payments of imports are currently made on terms.

 

 

Other comments:

 

The Company maintains a regular business.

 

The Company is in good standing.

This means that all local and federal taxes were paid on due date.

 

The risk is low.

 

 

Our opinion:

 

A business connection may be conducted.

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.60.43

UK Pound

1

Rs.100.23

Euro

1

Rs.80.35

 

INFORMATION DETAILS

 

Analysis Done by :

SUB

 

 

Report Prepared by :

NIS

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

 

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.